Treatment fluid devices methods and systems

US12564664B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12564664-B2
Application numberUS-202318200666-A
CountryUS
Kind codeB2
Filing dateMay 23, 2023
Priority dateOct 30, 2015
Publication dateMar 3, 2026
Grant dateMar 3, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A conductivity measurement device includes first and second conductivity measurement flow channels positioned in a fluid circuit and fluidly linked for fluid flow between the first and second conductivity measurement flow channels. A controller having a current source connected to the first and second conductivity channels applies alternating voltages at frequencies that are different, each being respective to one of the first and second conductivity cells.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of providing dialysate, comprising: filling first and second containers with first and second concentrate components for a sodium lactate-based dialysate solution, the first and second concentrate components, when combined in a predefined ratio and diluted with water, forming a functional dialysate suitable for a dialysis treatment; the first and second concentrate components being constituted such that sodium lactate is at least partly separated from sodium chloride and glucose to an extent such that no precipitation occurs in either container after storage for a period of at least two days while a level of concentration of the first and second concentrate components are such that if the first and second concentrate components are combined and stored for the period of at least two days, a precipitation would occur in a combination of the first and second concentrate components. 2 . The method of claim 1 , further comprising providing the first and second containers to a treatment site and combining and diluting the first and second concentrate components to form a dialysate for treatment. 3 . The method of claim 1 , further comprising, sterilizing internal surfaces of said first and second containers prior to said filling. 4 . The method of claim 3 , further comprising, sterile filtering said first and second concentrate components prior to said filling. 5 . The method of claim 1 , wherein the first concentrate component includes sodium chloride and glucose and the second concentrate component includes sodium lactate. 6 . The method of claim 5 , wherein the sodium lactate has a concentration of at least 35 mEq. 7 . The method of claim 6 , wherein the second concentrate component includes no glucose. 8 . The method of claim 7 , wherein the second concentrate component includes no sodium chloride. 9 . The method of claim 1 , wherein the first and second concentrate components contain glucose and the second concentrate contains no sodium chloride. 10 . The method of claim 9 , wherein the second concentrate component contains less glucose than the first concentrate component. 11 . The method of claim 1 , wherein the first and second concentrate components both contain sodium lactate, the second concentrate component containing a higher concentration of sodium lactate than the first concentrate component. 12 . A dialysate concentrate article of manufacture, comprising: first and second containers containing first and second concentrate components for a sodium lactate-based dialysate solution, the first and second concentrate components, when combined in a predefined ratio and diluted with water, forming a functional dialysate suitable for a dialysis treatment; the first and second concentrate components being constituted such that sodium lactate is at least partly separated from sodium chloride and glucose to an extent such that no precipitation occurs in either container after storage for a period of at least two days while a level of concentration of the first and second concentrate components are such that if the first and second concentrate components are combined and stored for the period of at least two days, a precipitation would occur in a combination of the first and second concentrate components. 13 . The article of manufacture of claim 12 , wherein the first and second containers are suitable for storage and transport to a treatment site and are constructed for connection to a predefined system for diluting the first and second concentrate components to form a dialysate for treatment. 14 . The article of manufacture of claim 12 , wherein internal surfaces of said first and second containers are sterile. 15 . The article of manufacture of claim 12 , wherein the first concentrate component includes sodium chloride and glucose and the second concentrate component includes sodium lactate. 16 . The article of manufacture of claim 12 , wherein the first concentrate component includes sodium chloride and glucose and the second concentrate component includes sodium lactate at a concentration of at least 35 mEq. 17 . The article of manufacture of claim 16 , wherein the second concentrate component includes no sodium chloride. 18 . The article of manufacture of claim 16 , wherein the second concentrate component includes no glucose. 19 . The article of manufacture of claim 12 , wherein the second concentrate component contains less glucose than the first concentrate component. 20 . The article of manufacture of claim 12 , wherein the first and second concentrate components both contain sodium lactate, the second concentrate component containing a higher concentration of sodium lactate than the first concentrate component.

Assignees

Inventors

Classifications

  • at least one cassette surface or portion thereof being flexible, e.g. the cassette having a rigid base portion with preformed channels and being covered with a foil · CPC title

  • Details of incorporated reservoirs · CPC title

  • Details of valves · CPC title

  • with treatment-fluid pumping means or components thereof · CPC title

  • with sensing means or components thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12564664B2 cover?
A conductivity measurement device includes first and second conductivity measurement flow channels positioned in a fluid circuit and fluidly linked for fluid flow between the first and second conductivity measurement flow channels. A controller having a current source connected to the first and second conductivity channels applies alternating voltages at frequencies that are different, each bei…
Who is the assignee on this patent?
Nxstage Medical Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/1668. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).